Statins augment efficacy of EGFR-TKIs in patients with advanced-stage non-small cell lung cancer harbouring KRAS mutation.
about
Additive Anti-Tumor Effects of Lovastatin and Everolimus In Vitro through Simultaneous Inhibition of Signaling PathwaysStatin improves survival in patients with EGFR-TKI lung cancer: A nationwide population-based study.Inhibition of SREBP increases gefitinib sensitivity in non-small cell lung cancer cells.Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pravastatin Added to First-Line Standard Chemotherapy in Small-Cell Lung Cancer (LUNGSTAR).YAP and TAZ in Lung Cancer: Oncogenic Role and Clinical Targeting.Do statins improve outcomes for patients with non-small cell lung cancer? A systematic review and meta-analysis protocol
P2860
Statins augment efficacy of EGFR-TKIs in patients with advanced-stage non-small cell lung cancer harbouring KRAS mutation.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Statins augment efficacy of EG ...... ncer harbouring KRAS mutation.
@en
type
label
Statins augment efficacy of EG ...... ncer harbouring KRAS mutation.
@en
prefLabel
Statins augment efficacy of EG ...... ncer harbouring KRAS mutation.
@en
P2093
P2860
P50
P1433
P1476
Statins augment efficacy of EG ...... ancer harbouring KRAS mutation
@en
P2093
Jindrich Finek
Milos Pesek
Ondrej Fiala
Zbynek Bortlicek
P2860
P2888
P304
P356
10.1007/S13277-015-3249-X
P577
2015-02-22T00:00:00Z
P5875
P6179
1040315077